← FDA Drug Approvals (Drugs@FDA)

LEVOFLOXACIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2020-04-22

Drug application

FDA Application #
ANDA205540
Application type
Abbreviated New Drug Application (Generic)
Brand name
LEVOFLOXACIN
Generic name
LEVOFLOXACIN
Active ingredients
LEVOFLOXACIN
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
GLAND
Manufacturer
Gland Pharma Limited
First approval
2020-04-22

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown